Thursday, July 9, 2026

pharma · Diabetic Kidney Disease · ZVSA

ZyVersa Therapeutics

ZyVersa Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Weston, USA HQ
2014 Founded
11 Employees
Public company Type
ZVSA · NYSE Ticker
Company details
Status
Public
HQ
Weston, USA
Founded
2014
Employees
11
Programs
1
Drugs
0
Patents
0
Intelligence · Drug Pipeline

ZyVersa Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

ZyVersa Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →